SCHEMBL5708874

SCHEMBL5708874

Oc1ccc2c(c1O)CCN(C(=S)NCCc1ccc(F)cc1)C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.53
▸ MEN1 O00255 5/20 0.53
▸ KMT2A Q03164 5/20 0.53
▸ NPC1 O15118 5/20 0.53
▸ ALDH1A1 P00352 6/20 0.51
▸ MAPT P10636 5/20 0.51
▸ LMNA P02545 2/20 0.51
▸ POLB P06746 2/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ GMNN O75496 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ ALOX12 P18054 1/20 0.51
▸ NFKB1 P19838 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6102970 0.89 NPC1 (0.53) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1
SCHEMBL5708803 0.89 NPC1 (0.53) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1
SCHEMBL5708795 0.89 KMT2A (0.65) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1
SCHEMBL5708762 0.89 NPC1 (0.68) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1
SCHEMBL6102910 0.87 KMT2A (0.60) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1
SCHEMBL5708871 0.86 SMN1; SMN2 (0.49) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1
SCHEMBL5708842 0.86 MEN1 (0.50) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1
SCHEMBL5708770 0.86 MEN1 (0.50) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1
SCHEMBL5708915 0.84 KMT2A (0.48) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1
SCHEMBL5708964 0.84 MAPT (0.53) SMN1; SMN2MEN1KMT2ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1708999-A1 BRONCHORELAXING COMPOUNDS RESPIRATORIUS AB (SE) 2006-10-11 — — EP disclosed
US-20060040919-A1 Bronchorelaxing compounds RESPIRATORIUS AB (SE) 2006-02-23 — — US disclosed
WO-2005070887-A1 BRONCHORELAXING COMPOUNDS RESPIRATORIUS AB (SE) 2005-08-04 — — WO disclosed
US-20050165004-A1 Bronchorelaxing compounds RESPIRATORIUS AB (SE) 2005-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050165004-A1 Bronchorelaxing compounds GPR6, CHRM3, NR1H3 SMN1; SMN2 2872/4885MEN1 1409/4885KMT2A 3030/4885
US-20060040919-A1 Bronchorelaxing compounds CHRM3, GPR3, CHRM2 SMN1; SMN2 2618/4885MEN1 2210/4885KMT2A 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback